Pharmageddon Blog

Attention: Behavioural science and vaccine hesitancy

Access to medicines—especially vaccines—isn’t just about availability, it's about human behavior. What patients do and the drugs they want to take depend on psychological and social factors that it's pharma’s job to address, no matter where these instincts come from.

Read More →

Attention: Gen-Z voices in pharma

Do I have your attention yet? Is your imagination whirling with ideas for structure disruption? Have you formed your own ideas for a techy transformation of the meaning of healthcare? How’s this for something that you’re almost probably ignoring, but definitely shouldn’t be: the rising tide of Generation-Z.

Read More →

Audacity: Beyond Medicine

You might think pharma’s bread and butter, saving lives, is already audacious enough. But in 2025, that’s not good enough. The power of new technologies, the shifting ground of patient perspectives and a changing business environment have changed the nature of our work. We need a new direction and we need to be audacious to find it.

Read More →

Pharmageddon: A manifesto

Many pharma conferences are, ultimately, self-congratulatory gatherings. They’re preoccupied with the immediate, the marginal and the minimal.

Read More →

Introducing: The 4As of Pharmageddon

Pharmageddon is not a normal pharma event. We don’t do vendor presentations. We’re not interested in press releases masquerading as ‘inspiring keynotes’. There’s no exhibition.

Read More →

Contact Us.

Email Lucy Osborne at [email protected]